Collagen Solutions PLC Collagen supply agreement to Yucel Medical
28 September 2015 - 4:02PM
RNS Non-Regulatory
TIDMCOS
Collagen Solutions PLC
28 September 2015
Collagen Solutions Plc
(the "Company" or the "Group")
Supply Agreement with Yucel
Collagen Solutions plc (AIM: COS), the developer and
manufacturer of medical grade collagen components for use in
regenerative medicine, medical devices and in-vitro diagnostics,
announces that its subsidiary Collagen Solutions Inc. has signed a
supply agreement with Turkish medical device company YĆ¼cel Medikal
Ltd (Yucel)
This supply agreement covers the provision of collagen materials
and support services for use in Yucel's product Lyocoll which is
currently on sale in Turkey. Lyocoll is a local haemostatic used in
all types of surgery to control capillary and venous bleeding as
well as oozing where the conventional methods are impractical and
ineffective.
Commenting on the agreement Dr Stewart White, CEO of Collagen
Solutions, said: "Collagen Solutions is pleased to have signed
another supply agreement with our valued customer Yucel to provide
materials for their haemostatic product Lyocoll. This supply
agreement further demonstrates the range of products that our
medical grade collagens are suitable for and the global nature of
our reach."
Senol Yucel, CEO of Yucel added: "Consistency of product and
continuity of supply are two very important factors for us and we
have carried out a thorough review of the capabilities of Collagen
Solutions to deliver the specific collagen that we require for
Lyocoll. We are therefore pleased to be able to sign this agreement
with a company which we can trust to deliver a quality product for
us."
Enquiries:
Collagen Solutions Plc
David Evans, Chairman Tel: 07740 084 452
Stewart White, CEO Tel: 0141 648 9100
Panmure Gordon & Co (Nomad and Tel: 0207 8862 714
Broker) Tel: 0207 886 2905
Robert Naylor (Corporate Finance)
Maisie Atkinson (Corporate Broking)
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
Mike Wort Mob: 07900 608 002
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAPGUGABUPAUAR
(END) Dow Jones Newswires
September 28, 2015 02:02 ET (06:02 GMT)
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Healthcare Inv (London Stock Exchange): 0 recent articles
More Healthcare Inv News Articles